Back

Positive effects of intravenous 5-lipoxygenase inhibitor quercetin in acute ST elevation myocardial infarction: intermediate results of ongoing randomized open blinded multicenter study

17 October 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 5 - Acute coronary syndrome - ST-elevation myocardial infarction ST-elevation myocardial infarction - ACS ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Associate Professor Yaroslav Lutay

NSC Strazhesko Institute of Cardiology and Clinical Medicine, Kiev (Ukraine)

20 More presentations in this session

Presentation thumbnail
Doctor M. Xiao (LIAOCHENG, CN)
Abstract Slides
Presentation thumbnail
Miss G. Kayumova (Moscow, RU)
Presentation thumbnail
Doctor A. Scarlatescu (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Doctor M. Moriya (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Doctor M. Coutinho Cruz (Lisbon, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Acute coronary syndrome - ST-elevation myocardial infarction

The Event

Event poster

Acute Cardiovascular Care 2016

17 October 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
28 August 2020
thumbnail
Congress Presentation
Quercetin blocks senescence-related cardiorenal fibrosis induced by hypertension
1 September 2025
thumbnail
Congress Session
Ventricular storm (3)
31 March 2025
thumbnail
Congress Presentation
Effect of 5-lipoxygenase-activating protein inhibiton on coronary atherosclerosis progression in patients with recent acute coronary syndrome: the PASSIVATE randomised clinical trial
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources